State Street Corp Acquires 5% Stake in Telix Pharmaceuticals
Company Announcements

State Street Corp Acquires 5% Stake in Telix Pharmaceuticals

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

State Street Corporation has emerged as a substantial holder in Telix Pharmaceuticals Limited, holding a 5.12% stake with 17,126,445 votes as of 24th July 2024. The details of the voting power, relevant interests, and considerations for the shares acquired were formalized in a notice filed on 26th July 2024.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyTelix announces Cardinal Health as U.S. commercial distributor for Zircaix
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Seeks New Shares Quotation
TheFlyTelix says IPAX-1 Phase I study published in Neuro-Oncology Advances
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App